Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.

Journal: Current therapeutic research, clinical and experimental
Published Date:

Abstract

OBJECTIVE: The post-reconstitution chemical stability and microbial challenge hold time of nonpreserved telavancin for injection was determined using common reconstitution diluents and intravenous (IV) infusion solutions stored at room temperature with light (ambient) or at 2°C to 8°C without light (refrigeration).

Authors

  • Zhengtian Gu
    Theravance Biopharma US, Inc, South San Francisco, California.
  • Carlos Parra
    Theravance Biopharma US, Inc, South San Francisco, California.
  • Anissa Wong
    Theravance Biopharma US, Inc, South San Francisco, California.
  • Alice Nguyen
    Theravance Biopharma US, Inc, South San Francisco, California.
  • Ronnie Cheung
    Theravance Biopharma US, Inc, South San Francisco, California.
  • Thomas Catalano
    Theravance Biopharma US, Inc, South San Francisco, California.

Keywords

No keywords available for this article.